Cite
HARVARD Citation
Geldenhuys, H. et al. (2015). The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial. Vaccine. 33 (30), pp. 3592-3599. [Online].